1. You are here:
  2. BioIndustry Association
  3. Member profile: Quell Therapeutics Ltd
Quell Logo2.jpg

Quell Therapeutics Ltd

R&D/Manufacturing

Website
https://quell-tx.com/
Membership category
Corporate

Translation & Innovation Hub, Level 3, London, W12 0BZ, United Kingdom

Quell Therapeutics Ltd at a glance

Quell Therapeutics is a London, UK based, exciting new cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions.

About Quell Therapeutics Ltd

Quell Therapeutics is a London based private bio-pharmaceutical company. At Quell we seek to deliver truly innovative, life-changing therapies for our patients. Our vision as a company is to build a major global biopharmaceutical company bringing transformational and valued therapies for a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation, based on modular engineered Tregs.

Therapeutic area(s)

  • Immunology/inflammation
  • Autoimmune diseases
  • ATMP

Articles Quell Therapeutics Ltd has contributed to

29 November 2021

CEO Update | 29 November 2021

I’m delighted to finally be able to leave the house today after my period of isolation after a positive COVID-19 test. It was such a shame not to be able to join our bioprocessing community last week for the 18th annual bioProcess UK conference but I have been enjoying looking at the photos from this great event. News over the weekend of the Omnicron variant has led to the postponement of the WTO Ministerial meeting in Geneva where waivers on the IP of COVID-19 vaccines were to be discussed, so I’m no longer expecting to see global policy set in Geneva this week.

Blog